Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
37.05
-0.79 (-2.09%)
At close: Sep 18, 2026, 4:00 PM EDT
37.63
+0.58 (1.57%)
After-hours: Sep 18, 2026, 7:37 PM EDT

Cue Biopharma Revenue

Cue Biopharma had revenue of $7.88M in the quarter ending June 30, 2026, with 166.66% growth. This brings the company's revenue in the last twelve months to $37.65M, up 354.37% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth.

Revenue (ttm)
$37.65M
Revenue Growth
+354.37%
P/S Ratio
7.15
Revenue / Employee
$1,298,448
Employees
29
Market Cap
269.15M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.